The Supreme Court has dismissed an appeal by Fortis Healthcare, allowing a forensic audit to trace assets linked to a 2016 Daiichi Sankyo arbitral award. The investigation centers on financial transactions involving the company's former promoters, marking a notable legal development in the ongoing dispute.
The Supreme Court of India has dismissed an appeal filed by Fortis Healthcare, clearing the path for a court-ordered forensic audit to trace assets related to a 2016 arbitral award. This award, which remains unexecuted, was secured by Japanese pharmaceutical firm Daiichi Sankyo following its earlier acquisition of Ranbaxy Laboratories.
The legal dispute is rooted in the actions of the company's former promoters, the Singh brothers. Fortis Healthcare had contested the audit, arguing that its current status as a listed entity with public shareholders should shield it from such scrutiny. However, the Supreme Court bench, led by Chief Justice Surya Kant, rejected this argument. During the proceedings, Justice Joymalya Bagchi observed that the company's status as a listed firm does not exempt it from investigative processes, particularly when the court views the entity as having acted as an 'enabler' of the judgment debtors.
For investors, it is important to distinguish between this legacy issue and the company's current operations. The matters being investigated relate to the era of the former promoters, which concluded several years ago. Since 2018, Fortis Healthcare has been managed by IHH Healthcare, which holds a controlling stake. The current management team operates under a different governance structure.
The forensic audit is intended to locate and trace assets to satisfy the 2016 international arbitral award. By upholding the Delhi High Court’s earlier directive, the Supreme Court has clarified that corporate layering or the presence of public shareholders cannot be used as a defense to delay or block the enforcement of legal judgments.
Historically, legal developments regarding the Singh brothers have often created a governance overhang for the stock. While this audit focuses on past transactions, the progress of the forensic examination remains a monitorable for shareholders, as it relates to the final settlement of long-standing liabilities linked to the former promoter group. The next phase will involve the implementation of the forensic audit as directed by the court.